| Literature DB >> 36070799 |
Tiffany Brown1, Brittany Zelch2, Ji Young Lee1, Jason N Doctor3, Jeffrey A Linder1, Mark D Sullivan4, Noah J Goldstein5, Theresa A Rowe1, Daniella Meeker3, Tara Knight3, Mark W Friedberg6,7, Stephen D Persell1,8.
Abstract
BACKGROUND: Requiring accountable justifications-visible, clinician-recorded explanations for not following a clinical decision support (CDS) alert-has been used to steer clinicians away from potentially guideline-discordant decisions. Understanding themes from justifications across clinical content areas may reveal how clinicians rationalize decisions and could help inform CDS alerts.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36070799 PMCID: PMC9451951 DOI: 10.1055/s-0042-1756366
Source DB: PubMed Journal: Appl Clin Inform ISSN: 1869-0327 Impact factor: 2.762
Fig. 1Accountable justification clinical decision support alert to reduce overtesting.
Documenting diagnosis or patient-reported symptom
| Theme | Clinical behavior accountable justification alert seeks to promote | Illustrative justifications | Physician review for clinical appropriateness |
|---|---|---|---|
| Diagnosis | Reducing opioid initial prescriptions and renewals | Uncertain | |
| Appropriate | |||
| Appropriate | |||
| Reducing high-risk polypharmacy | Uncertain | ||
| Symptom: pain | Reducing opioid initial prescriptions and renewals | Uncertain | |
| “10/10 radicular pain, tramadol for breakthrough” | Appropriate | ||
| Reducing high-risk polypharmacy | Uncertain | ||
| Symptom: general | Reduce PSA screening in the elderly | Appropriate | |
| “back pain, weight loss, rule out prostate cancer” | Appropriate | ||
| Reduce overtesting, UA/UC | “suprapubic tenderness and urgency” | Appropriate | |
| “cloudy urine with odor” | Inappropriate | ||
| Reducing high-risk polypharmacy | “burning skin sensation” | Uncertain |
Abbreviations: PSA, prostate-specific antigen; UA/UC, urinary albumin to urinary creatinine ratio.
Documenting contextual details defending clinical action
| Category | Clinical behavior accountable justification alert seeks to promote | Illustrative justifications | Physician review for clinical appropriateness |
|---|---|---|---|
| Pending another approach to pain management or care | Reducing opioid initial prescriptions and renewals | “Also trying other things” | Uncertain |
| “Bridging pain control until sees Spine for ESI [epidural steroid injection]” | Appropriate | ||
| “recent fractures, weaning off while starting new pain regimen” | Uncertain | ||
| Tapering plan | Polypharmacy | Appropriate | |
| Appropriate | |||
| Short-term supply of medication | Reducing opioid initial prescriptions and renewals | Appropriate | |
| “short term pain control, can't take nsaids, tylenol, conservative cares not working” | Appropriate | ||
| Failed alternative treatment | Reducing opioid initial prescriptions and renewals | Uncertain | |
| “have exhausted alternatives” | Appropriate | ||
| Appropriate | |||
| Appropriate | |||
| Polypharmacy | Appropriate | ||
| Appropriate | |||
| Chronic medication | Reducing opioid initial prescriptions and renewals | Uncertain | |
| Polypharmacy | Uncertain | ||
| Patient history | Reduce PSA screening in the elderly | Appropriate | |
| Reduce over-testing, UA/UC | Inappropriate | ||
| Reducing opioid initial prescriptions and renewals | Uncertain | ||
| Pre/Post-op | Reduce overtesting, UA/UC | Inappropriate | |
| Reducing opioid initial prescriptions and renewals | Uncertain |
Abbreviations: PSA, prostate-specific antigen; UA/UC, urinary albumin to urinary creatinine ratio.
Documenting details from a clinician–patient discussion
| Category | Clinical behavior accountable justification alert seeks to promote | Illustrative justifications | Physician review for clinical appropriateness |
|---|---|---|---|
| Discussion: general | Polypharmacy | Uncertain | |
| Uncertain | |||
| Reduce PSA screening in the elderly | “Patient's father died prostate cancer at age XX he wants continued check” | Inappropriate | |
| “Pt insistence” | Inappropriate | ||
| Discussion: risks/benefits | Reducing opioid initial prescriptions and renewals | “risk and benefits discussed” | Uncertain |
| Uncertain | |||
| Polypharmacy | “benefits outweigh the risks, patient understands the risks” | Appropriate | |
| “Patient is aware of the risk for sedation and falls with the use of sleeping medications and acknowledges the risk” | Uncertain |
Abbreviation: PSA, prostate-specific antigen.
Clinical appropriateness of justifications by topic
| Targeted clinical behavior | Total | Appropriate | Inappropriate | Uncertain appropriateness |
|---|---|---|---|---|
| Reduce PSA screening in the elderly | 15 | 9 (60%) | 6 (40%) | 0 |
| Reduce overtesting, urine studies | 23 | 14 (61%) | 7 (30%) | 2 (9%) |
| Reducing initial opioid prescriptions | 233 | 44 (19%) | 7 (3%) | 182 (78%) |
| Reducing renewal opioid prescriptions | 98 | 27 (28%) | 1 (1%) | 70 (71%) |
| Reducing high-risk polypharmacy | 191 | 66 (35%) | 11 (6%) | 114 (60%) |
| Total | 560 | 167 (29%) | 34 (6%) | 378 (65%) |
Abbreviation: PSA, prostate-specific antigen.